Iterum Therapeutics Stock (NASDAQ: ITRM) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 306.17K |
Day Range | - - - |
52 Wk Range | 0.62 - 2.50 |
Market Cap | $24.30M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 1.01% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Iterum Therapeutics (NASDAQ:ITRM) through any online brokerage.
Other companies in Iterum Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Cocrystal Pharma (NASDAQ:COCP), CalciMedica (NASDAQ:CALC), Ocuphire Pharma (NASDAQ:OCUP) and Lipocine (NASDAQ:LPCN).
Iterum Therapeutics has a consensus price target of $5.00.
The stock price for Iterum Therapeutics (NASDAQ: ITRM) is $1.07 last updated September 19, 2024 at 5:56 PM EDT.
There are no upcoming dividends for Iterum Therapeutics.
Iterum Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Iterum Therapeutics.
Iterum Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.